iNova Pharmaceuticals
iNova Pharmaceuticals is a healthcare company specializing in the development and marketing of over-the-counter and prescription medications. Based in Australia and New Zealand, its product portfolio spans various therapeutic areas such as weight management, pain relief, dermatology, cardiology, respiratory health, allergy, and women's health. The company aims to enhance human health and well-being by providing high-quality pharmaceutical products and services to patients and consumers.
Top Regions
Top Stages
1 past transactions
Mundipharma International
Acquisition in 2023
Mundipharma International is a pharmaceutical company with over six decades of experience, dedicated to improving patient care through innovative medicines. The company specializes in pain management, offering immediate and controlled-release formulations and analgesics. In addition to its strong focus on pain management, Mundipharma has expanded its portfolio to include treatments in respiratory, oncology, and biosimilar therapeutic areas. By prioritizing patient needs and leveraging its expertise, the company aims to transform its presence in emerging markets, fostering growth in antisepsis, respiratory health, and consumer healthcare. Mundipharma's commitment to innovation and entrepreneurship has established it as a leader in developing meaningful medicines that address challenging health conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.